We are a clinical stage private company focused on developing therapies for inflammatory diseases through a portfolio built around plasma gelsolin (pGSN). pGSN is a naturally occurring human protein that is at the core of a system to regulate the innate immune response, the first line of defense against both infectious and non-infectious health threats...
BioAegis Therapeutics develops novel protein replacement therapies targeted at saving lives based on the endogenous human protein, plasma gelsolin (pGSN).